---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-000044"
form_type: "8-K"
ticker: "RVTY"
cik: "0000031791"
company_name: "REVVITY, INC."
filed_at: "2022-01-11T23:59:59+00:00"
generated_at: "2026-06-27T19:06:51.858759+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# PerkinElmer raises Q4 2021 outlook: adj. EPS at least $2.40, non-COVID organic growth ~10%

## Summary
- Q4 2021 adjusted EPS expected at least $2.40, above prior guidance.
- Q4 non-COVID organic growth ~10%; full-year 2021 non-COVID organic growth ~16%.
- Q4 COVID-related revenue ~$320M; full-year COVID revenue over $1.5B.
- Full-year 2021 total revenue ~$5.0B: Diagnostics ~$2.9B, Discovery & Analytical Solutions ~$2.1B.

## SEC filing metadata
- accession: 0001157523-22-000044
- form_type: 8-K
- ticker: RVTY
- cik: 0000031791
- company_name: REVVITY, INC.
- filed_at: 2022-01-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/31791/000115752322000044/0001157523-22-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/31791/000115752322000044/a52560227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-000044
- JSON: https://secwatch.observer/filing/0001157523-22-000044.json
- Plain text: https://secwatch.observer/filing/0001157523-22-000044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.